Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-10-005807
Filing Date
2010-11-24
Accepted
2010-11-24 14:30:17
Documents
1
Period of Report
2010-11-23

Document Format Files

Seq Description Document Type Size
1 c63460_ex.html 4  
1 c63460_ex.xml 4 6930
  Complete submission text file 0000930413-10-005807.txt   8986
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address DORSEY & WHITNEY LLP 250 PARK AVENUE NEW YORK NY 10177
Business Address
Davit Paul Stephen (Reporting) CIK: 0001323791 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 101214621